The Cardio Genetics test is a cutting-edge analysis of your DNA, designed to uncover inherited risk factors that contribute to heart disease, stroke, and metabolic disorders. Using a simple blood sample, this test evaluates key genetic variants (SNPs) involved in cholesterol metabolism, blood pressure regulation, inflammation, blood clotting, and drug response. In partnership with your healthcare provider, Cardio Genetics provides a detailed report showing how your unique genetic profile impacts cardiovascular risk, often before symptoms appear or standard labs could be abnormal. The test empowers you and your provider with actionable, precision medicine insights to support personalized prevention, early intervention, and lifelong heart health.
Disrupted lipid metabolism is a silent driver of cardiovascular disease and is deeply influenced by genetics. Variants in APOA5 and LPL affect triglyceride clearance and remnant particles, while APOE isoforms shape lipoprotein transport and PCSK9/LDLR variants regulate LDL-receptor activity and LDL levels. When these pathways are unbalanced, triglycerides rise, atherogenic remnants and small dense LDL accumulate, and plaque formation accelerates, often before symptoms appear. Testing for these variants reveals a genetic tendency toward atherogenic lipids, enabling earlier intervention with targeted nutrition, lifestyle strategies, and personalized therapy to protect long-term vascular health.